These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7540222

  • 1. [An enzyme-linked immunosorbent assay determining anti-principal neutralizing determinant antibodies using synthetic peptides deduced from cDNA sequences of HIV-1 V3 loop domain].
    Ishimoto S, Fujimura Y, Yamanaka T, Shimoyama T, Nishida S, Matsuoka H, Nishikawa K, Yoshioka A, Narita N, Honda M.
    Rinsho Ketsueki; 1995 Mar; 36(3):193-9. PubMed ID: 7540222
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice.
    Cruz LJ, Quintana D, Iglesias E, Garcia Y, Huerta V, Garay HE, Duarte C, Reyes O.
    J Pept Sci; 2000 May; 6(5):217-24. PubMed ID: 10823490
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
    Rubinstein A, Goldstein H, Pettoello-Mantovani M, Mizrachi Y, Bloom BR, Furer E, Althaus B, Que JU, Hasler T, Cryz SJ.
    AIDS; 1995 Mar; 9(3):243-51. PubMed ID: 7755912
    [Abstract] [Full Text] [Related]

  • 4. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.
    J Pept Sci; 1995 Mar; 1(2):109-23. PubMed ID: 9222988
    [Abstract] [Full Text] [Related]

  • 5. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 01; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

  • 10. [Synthesis and comparative analysis of antigenic activity of peptides from hypervariable region V3 of human immunodeficiency virus I gp120 surface glycoprotein].
    Semiletov IuA, Rzhaninova AA, Garaev MM.
    Bioorg Khim; 1994 Oct 15; 20(10):1070-9. PubMed ID: 7826406
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL, Johansson B, Hjalmarsson S, Christensson B, Ljungberg B, Al-Khalili L, Sjölund M, Pipkorn R, Fenyö EM, Blomberg J.
    J Med Virol; 1999 Oct 15; 59(2):169-79. PubMed ID: 10459152
    [Abstract] [Full Text] [Related]

  • 13. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
    Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C.
    J Immunol; 1993 Aug 01; 151(3):1646-53. PubMed ID: 8335949
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of synthetic peptides for the detection of antibodies against human immunodeficiency virus].
    Lottersberger J, Salvetti JL, Tonarelli G.
    Rev Argent Microbiol; 2003 Aug 01; 35(3):149-55. PubMed ID: 14587377
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation of titer of antibody to principal neutralizing domain of HIVMN strain with disease progression in Japanese hemophiliacs seropositive for HIV type 1.
    Yamanaka T, Fujimura Y, Ishimoto S, Yoshioka A, Konishi M, Narita N, Mimaya J, Meguro T, Nakasone T, Okamoto Y, Yoshizaki H, Yamada K, Honda M.
    AIDS Res Hum Retroviruses; 1997 Mar 01; 13(4):317-26. PubMed ID: 9071431
    [Abstract] [Full Text] [Related]

  • 17. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP, Pestano GA, Harewood K, Alfred LJ, Guyden J, Boto WM.
    Cell Mol Biol (Noisy-le-grand); 1995 Mar 01; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [Abstract] [Full Text] [Related]

  • 18. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 19. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY, Hariharan K, Posner MR, Nara P.
    J Immunol; 1993 Jul 01; 151(1):449-57. PubMed ID: 7686944
    [Abstract] [Full Text] [Related]

  • 20. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A, Feigelson DJ, Hayek Y, Anglister J.
    Biochemistry; 1997 Jul 15; 36(28):8619-27. PubMed ID: 9214308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.